FDA Inspection
AmbioPharm, IncAmbioPharm, Inc – FDA Inspection, Jul 5, 2017
Record Details
This FDA Inspection record concerns AmbioPharm, Inc, with an inspection on July 5, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
- People
- Ileana Barreto-Pettit (Issuing Officer)
- Sonya M. Edmonds (FDA Associated Person)
View Company Profile
ID · 034acc5a-11fe-467b-89ef-f72b1cbff8e4
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1018621
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of AmbioPharm, Inc
5| Date | Classification | Office | Project area |
|---|---|---|---|
| February 9, 2023 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| October 9, 2014 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 28, 2013 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 16, 2011 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 4, 2008 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for AmbioPharm, Inc
- FDA Inspection 1196909 - 2023-02-09
- FDA Inspection 900896 - 2014-10-09
- FDA Inspection 826320 - 2013-03-28
- FDA Inspection 740844 - 2011-08-16
- FDA Inspection 546751 - 2008-11-04
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.